二甲双胍治疗糖耐量减低的循证医学研究与评价

被引:22
作者
张海燕
刘国良
机构
[1] 中国医科大学第一临床学院内分泌科
[2] 中国医科大学第一临床学院内分泌科 沈阳
关键词
二甲双胍; 糖尿病; 安慰剂; 代谢病; 空白剂; 糖耐量减低; IGT; 胰岛素抵抗; 循证医学;
D O I
暂无
中图分类号
R587.1 [糖尿病];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:298 / 299
页数:2
相关论文
共 7 条
[1]  
The Diabetes Prevention Program ( DDP) : reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. Knowler WC,Barrett-Connor E,Fowler SE,et al. The New England Journal of Medicine . 2002
[2]   饮食和运动干预治疗对糖尿病发病率的影响──530例糖耐量低减人群六年前瞻性观察 [J].
潘孝仁,李光伟,胡英华,王继兴,杨文英,安作新,刘娟,曹辉碧,胡泽溪,庞成言,张辉,郑辉,王金平,姜希贵,姜亚云 .
中华内科杂志, 1995, (02) :108-112
[3]  
Metformin, plasma glucose and free fatty acides in type 2 diabetic out-patients: results of a clinical study. Gregorio F,Ambrosi F,Manfrini S,et al. Diabetes Research and Clinical Practice . 1997
[4]  
Glucose tolerance, insulin secretion and insulin sensitivity in nonobese and obese Japanese subjects. Matsu moto K,Miyake S,Yano M,et al. Diabetes Care . 1997
[5]  
Insulin sensitivity indices calculated from basal and OGTT-induced insulin, glucose, and FFA level. Belfiore F,lannelo S,Volpicelli G. Molecular Genetics and Metabolism . 1998
[6]  
Review of previous impaired glucose tolerance intervention studies. Melander A. Diabetes Med, 1996 .
[7]  
Pharmacologic therapy for type 2 diabetes mellitus. DeFronzo RA. Annals of Internal Medicine . 1999